Immunoassays – News and Features

Prolonged use of renin-angiotensin system (RAS) inhibitors, common in hypertension treatment, can harm kidneys, leading to scarring, vascular changes and impaired filtration. Researchers found overstimulation of renin cells triggers damage over time.

Researchers have developed synthetic genes that function like the genes in living cells, offering a path toward using a suite of simple building blocks that can be programmed to make complex biomolecular materials.

A team at The University of Texas at El Paso has developed a microfluidic device that can quickly and affordably detect colorectal and prostate cancer. This innovative biochip eliminates the need for expensive equipment.

Newborn screening is a relatively easy and cost-effective way of improving the identification of babies with a medical condition in a timely fashion. This allows newborns to receive the treatment needed before irreversible damage has developed.

In this article, explore how next-generation protein sequencing is helping to unlock the proteome.

Bioprocessing involves the production of a high-value-added product from a living source. In this article, the stages of bioprocessing are described, with a focus on the central piece of this concept: the bioreactor.

Researchers have demonstrated a light-based method that detects coronavirus proteins.

Researchers investigated the ability of metformin to protect human cells and mice from DNA damage due to radiation exposure. If successfully repurposed, the drug has the potential to help at-risk groups, such as cancer patients and astronauts.

In this article, Asim Siddiqui explores the emerging ability of proteomics to reveal new biomarkers for disease.

KRAS inhibitors are showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment. Now, researchers have discovered a new mechanism of resistance that suggests an opportunity to make the treatment more effective.